PXMD

PaxMedica, Inc.

0.79 USD
-0.05 (-6.32%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PaxMedica, Inc. stock is down -74.1% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 December’s closed higher than November. 100% of analysts rate it a buy.

About PaxMedica, Inc.

PaxMedica is an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X tremor-ataxia syndrome (or FXTAS).